Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
about
Protease signalling: the cutting edgeThe crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine modelCaught in the act: the crystal structure of cleaved cathepsin L bound to the active site of Cathepsin LCathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescenceIncreased nucleolar localization of SpiA3G in classically but not alternatively activated macrophagesPhotodynamic quenched cathepsin activity based probes for cancer detection and macrophage targeted therapy.Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways.Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic CellsBiochemical Characterization and Substrate Specificity of Autophagin-2 from the Parasite Trypanosoma cruzi.Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain.Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.The endosome-lysosome pathway and information generation in the immune system.MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.Fast profiling of protease specificity reveals similar substrate specificities for cathepsins K, L and S.The human-specific invariant chain isoform Iip35 modulates Iip33 trafficking and function.Invariant Chain Complexes and Clusters as Platforms for MIF Signaling.Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.Bioinformatics analysis of potential essential genes that response to the high intraocular pressure on astrocyte due to glaucoma.Salivary Tick Cystatin OmC2 Targets Lysosomal Cathepsins S and C in Human Dendritic Cells.Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor.Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.Protease cleavage site fingerprinting by label-free in-gel degradomics reveals pH-dependent specificity switch of legumain.Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells.Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes.
P2860
Q26852301-1DB497D5-2C8B-4802-AD19-F4836EC39FDAQ27662251-EF6E2A17-DC0C-4433-AE84-0D3BA811F16EQ27704273-525D4C08-58F6-494B-B9BD-035682AC551FQ28508751-CA2CA746-180C-4E36-B1BD-B20B7573FC78Q28585591-68BCC204-E98C-4349-BE6B-BB344C5C1105Q30411275-4A0CA80F-95B0-4F55-98BB-4294D1C13AC7Q31123604-6374C84F-8A09-46AA-9C3E-7BD1BDF848F9Q35592746-BF1BA7A0-000C-4B50-88F0-3AA6DBA2AF1AQ35951395-679F4212-74E3-4540-ACB7-D6FD0ACB510FQ36301283-27881505-71FC-4960-91ED-A93069B04F16Q37065664-8A3588AA-77DB-44FB-8DBF-0F77C597D45AQ37389304-55E385F7-EA3F-411B-B7BB-6EE8A717EC23Q37826194-FBF03D32-0CD7-41AF-9C13-265CAB29A83BQ37904214-D748FBFE-F96D-47A0-95EA-20643C92A6C4Q38167996-2879F480-5B37-4658-B2AC-F92BFFCAC527Q38409707-47EC927D-D62F-48A4-95D6-DEA01B85DC3CQ38417182-82234439-DC00-41B8-8037-6699E3D201ABQ38979171-BDA498FD-E510-4C47-85BD-2F9A1B71792DQ39139156-ECFC24E4-7549-4914-8356-C36824FEE14AQ39700975-0957F6A1-378F-45B6-8DD7-1443735000ABQ40050354-F1529C3E-369D-4B04-9BE4-27F89C249151Q40990114-5593E276-1136-4310-B9F5-DB4FB562993AQ43123729-A0FDAA36-031F-47CF-99B3-CE0520D304F2Q43151758-E0C7ADF9-F892-4333-896E-7C7526A24C65Q46797867-7E71F9F4-2B69-4C0B-8B6E-C89FDBF4085BQ48364393-49519106-5101-4B95-AA8C-C7DC2571C3A3Q54321603-C0AF5642-BE66-489B-ADA5-32802800EEC6Q55023666-4FC41EFA-0DAE-4782-8CE9-3E88F6D69BD9
P2860
Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Inhibitory fragment from the p ...... psins in antigen presentation.
@en
Inhibitory fragment from the p ...... psins in antigen presentation.
@nl
type
label
Inhibitory fragment from the p ...... psins in antigen presentation.
@en
Inhibitory fragment from the p ...... psins in antigen presentation.
@nl
prefLabel
Inhibitory fragment from the p ...... psins in antigen presentation.
@en
Inhibitory fragment from the p ...... psins in antigen presentation.
@nl
P2093
P2860
P356
P1476
Inhibitory fragment from the p ...... epsins in antigen presentation
@en
P2093
Andreja Dobersek
Gregor Guncar
Marko Mihelic
P2860
P304
14453-14460
P356
10.1074/JBC.M801283200
P407
P50
P577
2008-03-24T00:00:00Z